Mesoblast Ltd

Activities: Manufacturing Regulatory Research & Development

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Graphs and graph data science in drug discovery Life sciences data expert Dr Alexander Jarasch discusses what work being done at the Institut de Recherches Servier can teach us about using modern data technologies for early...
  3. Why smaller CDMOs should enhance their operational efficiency now: a CPHI expert guide CPHI experts advise smaller CDMO's to invest in supply chain resilience, friend shoring and AI to keep up with the predicted uptick in funding for 2025
  4. CPI collaborates with industry leaders to expedite drug manufacturing via digitisation Digitising manufacturing technologies could allow enhanced ability to scale production, reduce costs and expedite the process
  5. Janssen to adopt Johnson & Johnson brand as the company celebrates 100 years of UK operation The company's pharmaceutical and medical technology segments will combine under the Johnson & Johnson brand name in the UK

Upcoming event

ASGCT Annual Meeting 2024

7-11 May, 2024 | Meeting | Portland, OR See all

Related Content

Manufacturing

Mesoblast picks Lonza to commercialise allogeneic cell therapy

The agreement provides for Lonza to expand its Singapore cGMP facilities if required to meet long-term growth and capacity needs for the product candidate
Manufacturing

Lonza and Mesoblast sign manufacturing pact

Lonza will produce adult stem cell products for Mesoblast
Subscribe now